CompanyBFRI BFRIWNasdaqWoburn, MA

Biofrontera Inc.

Biofrontera develops photodynamic therapy products for dermatological conditions.

SEC EDGAR ClinicalTrials.gov biofrontera-us.com

8-KSep 14Latest SEC filing, period to Sep 14

Aug 21Latest story

August 2026

Biofrontera's Phase 3 Ameluz trial for AK on extremities/neck posts results after completion

Aug 21Trial updateaminolevulinic acid Biofrontera Inc.

Biofrontera reports Q2 2026 results, cites pending sBCC decision and pipeline data

Aug 13Quarterly updateaminolevulinic acid Biofrontera Inc.